Sno.
|
Test Name
|
Amount
|
Min Qty
|
Ref. Value
|
1
|
D - DIMER (CITRATED PLASMA) |
1000 |
1 ml
|
LESS THAN 0.5 ugm FEU/ml : NEGATIVE MORE THAN 0.5 ugm FEU/ml : POSITIVE
|
2 |
D.FARINIAE ( d2) - SPECIFIC IgE |
600 |
1 ML
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
3
|
D.L. SPINE OBLIQUE (BOTH)
|
500 |
|
|
4 |
D.L.SPINE LATERAL VIEW
|
300 |
|
|
5
|
D.PTERONYSSINUS (d1) -SPECIFIC IgE |
600 |
1 ML
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
6 |
D.XYLOSE ABSORPTION TEST |
500 |
|
|
7
|
DENGUE IgG & IgM Abs. & NS 1 Antigen |
750 |
1 ml
|
|
8 |
Dengue IgG Antibody ELISA |
550 |
|
Reference Range:
Less than 18.0 : NEGATIVE 18.0 - 22.0 : EQUIVOCAL More than 22.0 : POSITIVE
IgG Ab to Dengue appear 6-15 days after infection
Negative: No detectable elevated IgG Levels.The patient probably does not have secondary infection. To rule out Acute infection , please do IgM ab or NS 1 Antigen or RT-PCR.
Positive: Suggestive of current Dengue infection with secondary Infection.Confirm with NS 1 Antigen RT -PCR or co presence of IgM Ab.
Equivocal: If Secondary dengue is clinically suspected pleases repeat the test at appropriate interval.
|
9
|
Dengue IgM Antibody ELISA |
550 |
|
Reference Range:
Less than 9.0 : NEGATIVE 9.0 - 11.0 : EQUIVOCAL More than 11.0 : POSITIVE
IgM Ab to Dengue appear 3 to 5 days after infection and can be present upto 90 days .
Negative: Dengue infection unlikely. Please also note the IgM Antibodies appear only after 3 days of infection and can be Negative in early Dengue. If early Dengue is suspected please do NS 1 Antigen or RT-PCR.
Positive: Highly suggestive of Dengue Fever. Treatment should be based on Platelet count, PCV and Clinical picture.
Equivocal: Dengue IgM Ab appear 3 to 5 days after infection and persist upto 90 days. Equivocal reports are due to either early testing or due to Immunodeficient states, or other Viral infections.
If clinically suspected please do Dengue IgG Abs, NS1 Antigen or RT-PCR.
|
10 |
DENGUE RNA BY RT - PCR |
3000 |
2 ml
|
|
11
|
Dengue Serotype by RT - PCR |
4000 |
|
|
12 |
DENTAL CHECKUP
|
100 |
|
|
13
|
Des.Gamma Carboxy Prothrombin (DCP) |
4000 |
|
Less Than 40 mAU/mL
Des-gamma carboxyprothrombin (DCP) also known as PIVKA II (Prothrombin induced by Vitamin K antagonist II) is an abnormal prothrombin that is increased in the sera of patients with Hepatocellular Carcinoma (HCC).
Unlike AFP, it is not elevated in Chronic Liver Disease, Cirrhosis, pregnancy or Germ Cell Tumors. It is a complementary biomarker to AFP in HCC and increases the sensitivity (83%) and specificity (84%) for HCC when used in combination.
It is recommended to measure two or more different tumor markers (AFP, DCP or AFP L3) for the diagnosis of HCC at an early stage.1,2
DCP has also been found to correlate better with tumor size, histological grade, portal vein invasion and /or intrahepatic metastasis in patients with HCC.
|
14 |
Desmoglein(DGS)1 & 3 Abs |
5000 |
|
|
15
|
DHEA |
1200 |
1 ml
|
MALES : 1.28 - 9.21 ng/ml FEMALES : 0.24 - 6.56 ng/ml
|
16 |
DHEA SULPHATE |
1200 |
1 ml
|
Females 10 - 14 yrs : 33.9 - 280 µg/dl 15 - 19 Yrs : 65.1 - 368 µg/dl 20 - 24 Yrs : 148 - 407 µg/dl 25 - 34 Yrs : 98.8 - 340 µg/dl 35 - 44 Yrs : 60.9 - 337 µg/dl 45 - 54 Yrs : 35.4 - 256 µg/dl 55 - 64 Yrs : 18.9 - 205 µg/dl 65 - 74 Yrs : 9.4 - 246 µg/dl Above 75 yrs : 12 - 154 µg/dl
Males 10 - 14 Yrs : 24.4 - 247 µg/dl 15 - 19 Yrs : 70.2 - 492 µg/dl 20 - 24 Yrs : 211 - 492 µg/dl 25 - 34 Yrs : 160 - 449 µg/dl 35 - 44 Yrs : 88.9 - 427 µg/dl 45 - 54 Yrs : 44.3 - 331 µg/dl 55 - 64 Yrs : 51.7 - 295 µg/dl 65 - 74 Yrs : 33.6 - 249 µg/dl Above 75Yrs: 16.2 - 123 µg/dl
Children 1 -12 Months : 3.4 - 124 µg/dl 1 - 4 Yrs :0.47 - 19.4 µg/dl 5 - 9 Yrs :2.8 - 85.2 µg/dl
|
17
|
Di.George Syndrome(22q 11.2 delection) |
4000 |
|
|
18 |
Diabetic Retinopathy - Both Eyes |
750 |
|
|
19
|
Diclofenac ( c 281)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
20 |
DIET COUNSELLING
|
100 |
|
|
21
|
DIFF. WBC COUNT |
50 |
|
|
22 |
Digene HPV Test |
1500 |
|
|
23
|
DIGOXIN |
1000 |
1 ml
|
Therapeutic Level : 0.8 - 2.0 ng/ml
Digoxin is a commonly used drug in the management of Congestive heart failure and Supraventricular tachycardia.
Increased sensitivity to Digoxin is noted in states of Hypokalemia, Hypomagnesemia and Hypercalcemia making establishment of true therapeutic concentration difficult because all parameters are interactive. There is a difference between peak plasma concentration and peak tissue concentration of Digoxin.
Clinically effective range for Digoxin is not determined at the peak plasma concentration (2-3 hours after oral dose), but rather at the time of peak tissue concentration (6-8 hours after oral dose). To ensure a correlation between plasma and tissue concentrations the appropriate time to collect the specimen is 8 hours or more after the dose.
|
24 |
DIHYDROTESTOSTERONE(DHT) |
2500 |
1.0 ml
|
Child Prepubertal : < 30 pg/ml
Adult Male : 250-990 pg/ml
Female : Pre Menopausal : 24-368 pg/ml Post Menopausal: 10-181 pg/ml
|
25
|
Disposable Charge
|
0 |
|
|
26 |
DMD (Duchenne Muscular Dystrophy Mutation) |
5000 |
|
|
27
|
DMDC - PCR(Duchenne Muscular Dystrophy)
|
8000 |
|
|
28 |
Dog dander (e 5) - SPECIFIC - IgE |
600 |
1 ml
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
29
|
Dog epithelium (e 2) - SPECIFIC - IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
30 |
DOPPLER - LT LOWER LIMB ARTERIAL
|
1200 |
|
|
31
|
DOPPLER - LT LOWER LIMB VEN & ART
|
2000 |
|
|
32 |
DOPPLER - LT LOWER LIMB VENOUS
|
1200 |
|
|
33
|
DOPPLER - OBSTETRICS STUDY
|
1000 |
|
|
34 |
DOPPLER - RT LOWER LIMB VEN & ART
|
2000 |
|
|
35
|
DOPPLER - RT LOWER LIMB VENOUS
|
1200 |
|
|
36 |
DOPPLER - SCROTAM
|
1200 |
|
|
37
|
DOPPLER BOTH LOWER LIMBS ARTERIAL
|
2000 |
|
|
38 |
DOPPLER BOTH LOWER LIMBS VEN&ART
|
4000 |
|
|
39
|
DOPPLER BOTH LOWER LIMBS VENOUS
|
2000 |
|
|
40 |
DORSAL SPINE AP & LAT
|
600 |
|
|
41
|
DORSAL LUMBAR SPINE AP & LAT
|
600 |
|
|
42 |
DPD(URINE) |
500 |
|
MALE 22-80 yrs : 5-14 nMol/mMol of creat FEMALE 20-45yrs : 5-22 nMol/mMol of crea
|
43
|
DRVVT( DILUTE RUSSEL VIPER VENOM TEST) |
500 |
|
|
44 |
ds - DNA AB ( Crithidia lucilae) by IF |
1000 |
1 ml
|
|
45
|
ds - DNA AB - Nc X - ELISA |
800 |
|
Less Than 1.0 Ratio: Negative
More than or equal to 1.0 Ratio: Positive
|